A forum for researchers, students and applicants in the field of cyclodextrin technology
Quercetin, a flavonoid with possible neuroprotective action has been recently suggested for the early-stage treatment of Alzheimer’s disease. The low
A clinical trial in United Kingdom confirms SaNOtize’s breakthrough treatment for COVID-19 SaNOtize R. & D. Corp, a Canadian Biotech
Researchers lead by Professor Michael S. Diamond at Washington University School of Medicine in St. Louis, have developed a COVID-19
Cyclodextrins have not been popular excipients for nasal or pulmonary drug delivery so far. This can change soon, with the
